Sunday - July 13, 2025
Frederick National Laboratory: Laboratory Develops Clinical Assay for Recurrent Thyroid Cancer
July 11, 2025
FREDERICK, Maryland, July 11 -- The National Institutes of Health's National Laboratory for Cancer Research issued the following news:

* * *

Laboratory develops clinical assay for recurrent thyroid cancer

The CLIA Molecular Diagnostics Laboratory (CMDL) at the Frederick National Laboratory for Cancer Research (FNL) developed and validated a blood test to detect recurrent thyroid cancer following surgical removal of the gland. It is now available for us . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products